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On becoming Th17 cells
T-helper 17 (Th17) cells, which are distinct from Th1- and Th2-
cell subsets, produce high levels of interleukin-17 (IL-17). 
Unfortunately, the high variability of human samples has made 
it difficult to identify the cytokines governing differentiation of 
these cells. Therefore, de Beaucoudrey and colleagues com-
pared the development of Th17 cells from healthy patients and 
patients with genetic errors that impair the signaling pathways 
involving transforming growth factor-β, IL-1, IL-6, or IL-23. Flow 
cytometric analysis revealed that signal transducer and activator 
of transcription-3 (STAT-3) is required for the maintenance and 
expansion of IL-17-secreting human T-cell blasts. Analysis of the 
mutant cells also indicated that IL-23 plays a role in this process, 
because null mutations in IL12B and IL12BR1 produced fewer 
IL-17-producing cells in vitro. These findings support a role for 
IL-6 signaling in Th17-cell differentiation and suggest that IL-23 
plays a role as well; however, a role for IL-21 cannot be excluded 
because STAT-3 is involved in all these pathways. These results 
provide an important piece of the puzzle for the understanding 
of differentiation of these specific helper T cells in humans. ( J Exp 
Med 205:1543–50, 2008)
Epidermis as endocrine
The transcription factor JunB-activator protein-1 has been 
implicated in keratinocyte differentiation, carcinogenesis, UV 
responses, and wound repair. In addition, downregulation of JunB 
in the epidermis results in lesions closely resembling psoriasis. 
Meixner and colleagues therefore inactivated JunB in mouse epi-
dermis and found that 2- to 3-month-old mice developed ulcer-
ative skin lesions with epidermal thickening, myeloproliferative 
disease (MPD), and bone loss. In-depth examination of these cells 
revealed that the levels of the cytokine G-CSFs were specifically 
increased, indicating that JunB negatively regulates cytokine 
expression in normal keratinocytes. Culture of wild-type kerati-
nocytes in medium from JunB-deficient cultured keratinocytes 
resulted in proliferation, and MPD did not develop in G-CSF-
deficient mice that lacked JunB in the epidermis. Together, these 
results suggest that MPD is caused by signals or factors, including 
G-CSF, that are released via JunB pathways in the epidermis in an 
endocrine manner. (Nat Cell Biol 10:1003–11, 2008)
Promises of a new inhibitor
Psoriasis is an autoimmune disease that involves infiltrates of 
T cells, macrophages, and dendritic cells, as well as hyper-
proliferation of epidermal keratinocytes. Protein kinase C (PKC) 
isoforms play important roles in cell signaling, proliferation, 
differentiation, survival, and cell death, and certain isoforms are 
critical in T and B cells. Recently, a novel PKC inhibitor, AEB071, 
was shown to exhibit a pharmacological profile consistent 
with inhibition of cells involved in the pathogenesis of auto-
immune diseases. Skvara and colleagues examined the safety, 
tolerability, and clinical effects of this PKC inhibitor in psoriasis 
patients. Remarkably, orally administered AEB071 was well tol-
erated by patients and inhibited PKC-dependent proliferation 
and IL-2 production by T cells activated ex vivo. Furthermore, a 
dose-dependent improvement in clinical severity and immuno-
histology was observed in psoriasis patients receiving a 2-week 
treatment regimen. These results present encouraging evidence 
that this novel kinase inhibitor may offer new therapy for psoriasis 
or other autoimmune diseases. ( J Clin Invest 118:3151–9, 2008)
STAT action promotes tumors
Immune cells have been implicated in promoting tumor invasion 
and angiogenesis, despite a conventional role in antitumor 
immunity. Myeloid-derived suppressor cells (MDSCs), along 
with tumor-associated macrophages (TAMs), produce angio-
genic factors and enhance tumor immune suppression. Signal 
transducer and activator of transcription-3 (STAT-3) is involved 
in tumor immune suppression. Indeed, STAT-3 activation in both 
MDSCs and TAMs was important for myeloid cell–mediated 
tumor angiogenesis, at least in part via upregulation of the 
angiogenesis-promoting factors vascular endothelial growth 
factor, basic fibroblast growth factor, and matrix metallo-
proteinase-9. In addition, STAT-3 activation in endothelial 
cells was also critical for tumor angiogenesis. Thus, STAT-3, 
which apparently mediates multidirectional cross-talk among 
tumor cells, tumor stromal myeloid cells, and endothelial cells, 
is crucial in tumor immune suppression and angiogenesis. 
( J Clin Invest 118:3367–77, 2008)
Clues to HIV-1 transmission
Although the biological mechanisms of sexual transmission 
of HIV are not well understood, genital coinfections have been 
linked to increased susceptibility to this virus. Microbes induce 
inflammatory cytokines and chemokines via interaction with Toll-
like receptors (TLRs) on epithelial cells or Langerhans cells (LCs). 
Recently, de Jong and colleagues examined whether inflamma-
tory cytokines induced by infection alter these cells, specifically 
LCs, which may be the first line of viral defense in the epidermis 
and mucosal epithelia. Although LCs are not efficiently infected 
by HIV-1, activation of these cells by tumor necrosis factor-α 
(TNF-α), a cytokine induced by Candida and Neisseria infec-
tions, or the TLR agonist Pam3CSK4 increased HIV-1 transmission 
in an ex vivo transmission model with human epidermal sheets. 
TNF-α increased transmission by increasing HIV-1 replication in 
LCs, whereas Pam3CSK4 enhanced transmission by increasing 
LC capture and trans-infection of T cells. Thus, coinfection of the 
genital tract with HIV and bacterial or fungal pathogens promotes 
inflammation and subsequently overcomes the protective func-
tion of LCs to ultimately enhance HIV-1 infection. ( J Clin Invest 
118:3440–52, 2008)
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